Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Evaluated by Multi-slice Spiral CT in Patients With Stable Coronary Heart Disease and Hyperlipidemia

NCT01382277 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT01382277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01382277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Evaluated by Multi-slice Spiral CT in Patients With Stable Coronary Heart Disease and Hyperlipidemia
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2011
Completion date
April 30, 2013
Enrollment
600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, hyperlipidemia